Discovery Laboratories Company Profile

23:52 EST 19th February 2020 | BioPortfolio

Discovery Laboratories, Inc. is a specialty pharmaceutical company leveraging its platform technology in humanized lung surfactants to develop novel respiratory therapies and pulmonary drug delivery products. Surfactants are produced naturally in the lungs and are essential to the lungs' ability to absorb oxygen.

Our humanized surfactant technology is being developed initially for critical care patients with life-threatening respiratory disorders where there are few or no approved therapies available. Surfaxin®, our lead product, is currently in Phase 3 clinical trials for Respiratory Distress Syndrome in premature infants (RDS), a Phase 3 clinical trial for Meconium Aspiration Syndrome in full-term infants (MAS), and a Phase 2 clinical trial for Acute Lung Injury/Acute Respiratory Distress Syndrome in adults (ALI/ARDS).

We are also developing aerosolized formulations of our humanized surfactant to treat respiratory conditions such as asthma and as a novel pulmonary drug delivery vehicle to render drugs more effective when delivered to or via the respiratory tract.

A lack of functional surfactant is associated with several severe respiratory diseases. Research has established that surfactant replacement is highly effective in treating RDS and holds great promise in treating MAS, ALI/ARDS, asthma and other respiratory disorders. However, RDS is the only respiratory disease being treated today with approved surfactants, which are principally animal derived. The current supply of these surfactants is limited and their manufacture is both inexact and expensive, making it difficult to develop these products to treat broader populations for RDS therapy or other respiratory diseases.

Because our products are based on an engineered humanized surfactant, they can be produced economically at scale, as a high quality pharmaceutical, without the risk of potential transmission of animal-borne diseases or adverse immunological reaction. Products from our technology platform have the potential to be superior to currently marketed surfactants, treat critical care respiratory conditions, and treat larger, ambulatory patient populations that could benefit from surfactant therapy or drug delivery.


2600 Kelly Road, Suite 100
United States of America


Phone: 215.488.9300
Fax: 215.488.9301

News Articles [514 Associated News Articles listed on BioPortfolio]

Clontech Laboratories, Inc.

Clontech Laboratories provides kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function. As the newest member of the Takara Bio Group, Clonte...

Takeda and Charles River enter drug discovery collaboration

Takeda Pharmaceutical Co. Ltd. penned a deal with CRO Charles River Laboratories Inc. for the discovery of preclinical programs across Takeda’s four areas of focus--oncology, gastroenterology, neuro...

Charles River Laboratories to buy HemaCare for $380m

HemaCare has expertise in the customisation of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development. HemaCare provides a ran...

Discovery by NETRF-funded researchers may help predict recurrence of pNETs

ARX and PDX1 levels can be measured using immunohistochemistry, a test that stains tumor tissue and is routine in clinical laboratories.

A2LA Accredits GEL Laboratories, LLC to ISO/IEC 17025

A2LA is pleased to announce the accreditation of GEL Laboratories to ISO/IEC 17025 for cannabis testing, specifically for hemp plant material, oils, and solids. GEL Laboratories is based in Charleston...

Invest Newcastle: Global Head of Neuroscience Discovery marks the official launch of The Biosphere

On Thursday 4 July Dr. Fiona Marshall, Global Head of Neuroscience Discovery, MSD visited Newcastle to mark the official launch of The Biosphere. Located at Newcastle Helix, The Biosphere is a sp...

Charles River Laboratories International, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $154

Charles River Laboratories International, Inc. Strategy, SWOT and Corporate Finance ReportSummaryCharles River Laboratories International, Inc. Strategy, SWOT and Corporate Finance Report, is a sour...

Charles River Laboratories International, Inc. Strategy, SWOT and Corporate Finance Report [Published by Marketline] Prices from USD $149

Charles River Laboratories International, Inc. Strategy, SWOT and Corporate Finance ReportSummaryCharles River Laboratories International, Inc. Strategy, SWOT and Corporate Finance Report, is a sour...

Drugs and Medications [64 Associated Drugs and Medications listed on BioPortfolio]

Salinocaine [medical products laboratories, inc.]


Keralyt [summers laboratories inc]


Tri-chlor [gordon laboratories]


Stiptik [island kinetics, inc. d.b.a. covalence laboratories]

OTC #301; Stiptik Swab (100) These highlights do not include all the information needed to use see full prescribing information for Initial U.S. Approval.

Ibu [dr. reddy's laboratories limited]

IBU Tablets

PubMed Articles [583 Associated PubMed Articles listed on BioPortfolio]

An overview of late-stage functionalization in today's drug discovery.

: Late-stage functionalization (LSF) can introduce important chemical groups in the very last steps of the synthesis. LSF has the potential to speed up the preparation of novel chemical entities and d...

Hemostasis critical values among Iranian clinical laboratories "National Survey of 157 Clinical Laboratories".

Immediate reporting of critical values or test results significantly outside the normal range has a growing role in the management of patients, especially in life-threatening conditions. Due to the la...

Proficiency test for rabies serology: A design complying with international standards for a reliable assessment of participating laboratories.

Domestic carnivores can introduce rabies into disease-free countries or areas if they are incubating the disease and transported during the pre-symptomatic period. For pets moved into the European Uni...

Performance assessment of medical diagnostic laboratories: A network DEA approach.

The main purpose of this paper is to measure the efficiency and ranking of medical diagnostic laboratories by applying a network data envelopment analysis (NDEA).

A 20-Year Evaluation of LOINC in the United States' Largest Integrated Health System.

Clinical laboratories are obligated to implement Logical Observation Identifier Names and Codes (LOINC), an informatics standard used to uniquely identify laboratory tests. The historical progress of ...

Clinical Trials [547 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

PCD New Gene Discovery

This is a new gene discovery program for individuals with PCD who do not have a specific genetic etiology identified. Research procedures involve a single blood draw from the affected indi...

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Collection and Distribution of Biospecimens for Novel Research Uses

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers ...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Companies [2179 Associated Companies listed on BioPortfolio]

JMI Laboratories

Established in 2000 by Ronald N. Jones, MD, JMI Laboratories serve as microbiology specialists in the development of antimicrobials. Our experienced professionals provide diverse and flexible services...

NCE Discovery Limited

nce discovery was spun out of the Wolfson Institute for Biomedical Research, University College London in 2001 and provides expert medicinal chemistry services to pharmaceutical and biotechnology comp...

Charleston Laboratories, Inc.

Charleston Laboratories Inc, headquartered in Charleston, SC, is a privately funded specialty pharmaceutical company developing and commercializing opioid drugs with minimal or no opioid-induced nause...

ChemBridge Research Laboratories, Inc.

ChemBridge Research Laboratories, Inc. (CRL),, is a San Diego based discovery chemistry CRO, which provides chemistry solutions for early stages of small molecule...


Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Discovery Laboratories" on BioPortfolio

We have published hundreds of Discovery Laboratories news stories on BioPortfolio along with dozens of Discovery Laboratories Clinical Trials and PubMed Articles about Discovery Laboratories for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Discovery Laboratories Companies in our database. You can also find out about relevant Discovery Laboratories Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...

Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Corporate Database Quicklinks

Searches Linking to this Company Record